Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial.

Obstetrics and gynecology·2008
Same author

Should symptomatic menopausal women be offered hormone therapy?

MedGenMed : Medscape general medicine·2007
Same author

Should symptomatic menopausal women be offered hormone therapy?

MedGenMed : Medscape general medicine·2006
Same author

Clinical opinion: the biologic and pharmacologic principles for age-adjusted long-term estrogen therapy.

MedGenMed : Medscape general medicine·2006
Same author

Clinical opinion: the biologic and pharmacologic principles of estrogen therapy for symptomatic menopause.

MedGenMed : Medscape general medicine·2006
Same author

Optimizing women's health: Adult Women's Health & Medicine.

Climacteric : the journal of the International Menopause Society·2006

Related Experiment Video

Updated: Jul 15, 2026

Studies on the Anti-Inflammatory Effect of Xiaoyao Pills in The Treatment of Postmenopausal Osteoporosis in Mice
07:20

Studies on the Anti-Inflammatory Effect of Xiaoyao Pills in The Treatment of Postmenopausal Osteoporosis in Mice

Published on: August 23, 2024

Postmenopausal tibolone therapy: biologic principles and applied clinical practice.

Morris Notelovitz1

  • 1mnotelo@aol.com

Medgenmed : Medscape General Medicine
|April 17, 2007
PubMed
Summary

Tibolone, a unique hormone therapy, offers tissue-specific benefits for menopausal symptoms by influencing estrogen, progesterone, and androgen activity. Its metabolites provide targeted effects, aiding in managing bone health, cardiovascular risks, and other menopausal concerns.

Related Experiment Videos

Last Updated: Jul 15, 2026

Studies on the Anti-Inflammatory Effect of Xiaoyao Pills in The Treatment of Postmenopausal Osteoporosis in Mice
07:20

Studies on the Anti-Inflammatory Effect of Xiaoyao Pills in The Treatment of Postmenopausal Osteoporosis in Mice

Published on: August 23, 2024

Area of Science:

  • Endocrinology
  • Pharmacology
  • Molecular Biology

Background:

  • Menopause biology varies individually due to genetic factors influencing hormone receptor and enzyme activity.
  • Molecular biology advances enable targeted pharmacologic agents based on organ-specific hormonal biology.
  • Tibolone, a progestin analogue, exhibits tissue-specific effects on hormone synthesis and metabolism.

Purpose of the Study:

  • To review the clinical utility of tibolone for symptomatic menopause.
  • To summarize tibolone's effects on bone health, cardiovascular disease, breast, and endometrium.
  • To discuss tibolone's role in clinical practice based on hormonal physiology.

Main Methods:

  • Review of postmenopausal estrogen and androgen synthesis and metabolism.
  • Analysis of tibolone's bioconversion into tissue-specific active metabolites (3alpha/3beta hydroxytibolone, delta4 tibolone).
  • Evaluation of tibolone's agonistic/antagonistic properties on estrogen, progesterone, and androgen receptors.

Main Results:

  • Tibolone metabolites possess tissue-specific estrogenic, progestogenic, and androgenic properties.
  • The drug influences endogenous sex steroid activity in target organs.
  • Clinical utility is reviewed concerning menopausal symptom management.

Conclusions:

  • Tibolone's unique mechanism offers targeted therapeutic benefits for menopausal symptoms.
  • Its tissue-specific actions are crucial for managing bone health, cardiovascular aspects, and reproductive tissues.
  • Tibolone represents a valuable therapeutic option in clinical practice for postmenopausal women.